November 5, 2018 Drug compounding is the process of combining (two or more drugs), mixing, or altering ingredients to create a medication tailored to the needs of an individual patient.[1]… Read more »
Elizabeth Whalley Buono will be presenting “Federal and State Responses to the Opioid Epidemic” at the Center for Disease Control’s (CDC) Annual meeting of The Prevention of Overdoses and Treatment… Read more »
October 25, 2018 This past week, as part of the U.S. Food and Drug Administration’s (FDA) goal of reducing serious adverse outcomes resulting from inappropriate prescribing and misuse and abuse… Read more »
Hancock Daniel joins VCU and Virginia Bio for an Inaugural Pharmacy Compounding Symposium in November Richmond, VA, October 19, 2018– This Inaugural Pharmacy Compounding Symposium will be held on Friday,… Read more »
October 2, 2018 On Sept. 24, 2018, the U.S. Food and Drug Administration (FDA) convened its seventh inter-governmental working meeting as part of its commitment to maintaining close communication with… Read more »
9/25/2018 Credentialing physicians is frequently an arduous process that takes several months to complete and involves hours of paperwork detailing every certification, academic experience and personal background. Thankfully, for Virginia… Read more »
September 21, 2018 On Monday September 17, 2018, with almost unanimous support, the Senate passed a package of 70 bills that collectively seek to address the myriad of challenges posed… Read more »
Elizabeth Whalley Buono will be presenting Scaling the Health Economy at the “Virginia Impact Summit” hosted by the Office of Governor Northam, the Virginia Impact Investing Forum & Social Entrepreneurship… Read more »
August 23, 2018 The Medicare Advantage sector is experiencing steady growth. From the increasing number of enrolled beneficiaries, to health insurers investing in this privatized version of traditional Medicare, to… Read more »
August 21, 2018 Unlike the regulatory prohibitions against drug and device manufacturers advertising and/or promoting use of their products off-label, doctors are free to responsibly use FDA-regulated products outside of… Read more »
